Early signs surrounding the XEC COVID-19 variant, which emerged in late 2024, initially caused concern among virologists. This Omicron descendant, formed through recombination of two other variants, appeared capable of evading immunity from past infections and existing vaccines. However, despite its potential for immune evasion, the anticipated surge in hospitalizations never materialized. Wastewater surveillance indicated widespread infection, but hospitalization rates were significantly lower than in previous winters.
This unexpected outcome has prompted researchers to investigate why COVID-19 seems to be causing milder illness. Several observations support this trend. Symptoms like loss of taste and smell are becoming less frequent. While hospitalizations and deaths still occur, the majority of infections are now asymptomatic or resemble mild colds, sometimes even mistaken for seasonal allergies. While immunocompromised individuals remain at risk, advanced age (over 75) now appears to be a major risk factor for severe illness.
Experts attribute this shift to several factors. One possibility is widespread hybrid immunity, resulting from repeated vaccinations and infections, creating a robust immune memory capable of swiftly eliminating new infections. This theory is supported by declining rates of long COVID, suggesting the virus is less able to persist and trigger aberrant immune responses. Another possibility is that the virus has reached a point of stability, evolving towards milder forms, similar to historical coronavirus outbreaks. This contrasts with influenza, which often undergoes more radical changes.
Despite the current trend towards milder illness, experts emphasize the importance of vaccination, especially for vulnerable groups, as it provides crucial protection against severe outcomes. They also caution against complacency, as there’s no guarantee that more virulent variants won’t emerge in the future. Long COVID also remains a concern.
Research also highlights the changing nature of COVID-19’s impact. Hospital treatment protocols have evolved, with less reliance on anticoagulants and a focus on antivirals. Studies indicate that COVID-19 now contributes a smaller proportion of hospital respiratory virus cases compared to other viruses.
Researchers are also exploring potential future trajectories for the virus. One area of investigation involves persistent gut infections with COVID-19. Studies of wastewater samples have revealed “cryptic lineages” of the virus, suggesting ongoing infections in some individuals. This raises the possibility that COVID-19 could eventually evolve into a fecal-oral virus, similar to norovirus, although experts consider this a long-term possibility.
Despite the current trend towards milder illness, ongoing research and surveillance remain crucial. Experts stress the importance of vaccination and continued development of next generation vaccines, including mucosal vaccines to prevent transmission and universal that don’t require frequent updates. While the immediate threat of severe illness has diminished for many, the evolving nature of COVID-19 necessitates continued vigilance and scientific investigation.
By
